Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
anti-cd19 car-t b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Hematopoietic Neoplasms[MeSHID:D019337]
Lymph[MeSHID:D008196]
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma[MeSHID:D054218]		 NA phase 1 unknown
anti-cd19 car-t b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymph[MeSHID:D008196]
Hematopoietic Neoplasms[MeSHID:D019337]		 NA phase 1 unknown
anti-cd19 car-t b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymph[MeSHID:D008196]
Hematopoietic Neoplasms[MeSHID:D019337]		 NA phase 1/2 unknown
anti-cd19 car-t b-lymphocyte surface antigen b4 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Hematopoietic Neoplasms[MeSHID:D019337]
Lymph[MeSHID:D008196]
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma[MeSHID:D054218]		 NA phase 1/2 unknown
click here to return to the previous page